Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EFFECT-CPE: FMT for CPE Eradication
NCT03802461Phase 3Suspended
- Start
- Mar 2019
- Primary completion
- Dec 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of allogeneic fecal microbiota in Enterobacteriaceae colonization. Started Mar 2019; status: suspended.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Enterobacteriaceae colonization
Beyond the preview
Go deeper on NCT03802461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03802461.